In week 4, you will notice significant appetite suppression, weight changes (due to loss of fat mass), less bloating, and elevated energy levels
Blood sugar below 54 mg/dL
Compounded oral GLP-1s are not FDA-approved and absorb differently than injectables, so discuss expectations with the prescribing clinician
To see long-term success, patients must find a treatment pathway with the right medication at the right dose, combined with personalised clinical support with the behavioural, nutritional and lifestyle support
Option 2: adding 2ml of bacteriostatic water to 10mg tirzepatide Adding 2ml of bacteriostatic water to a 10mg vial produces a concentration of 5mg/ml
Understanding the mechanisms behind this muscle loss, the factors that influence it, and evidence-based strategies to preserve muscle function helps patients and clinicians optimize treatment outcomes while maintaining strength and functional independence throughout therapy